168 related articles for article (PubMed ID: 23119315)
1. Itraconazole - a potent antifungal drug.
Panda NK
Indian J Otolaryngol Head Neck Surg; 1997 Jul; 49(3):293-4. PubMed ID: 23119315
[TBL] [Abstract][Full Text] [Related]
2. Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses.
Grant SM; Clissold SP
Drugs; 1989 Mar; 37(3):310-44. PubMed ID: 2540949
[TBL] [Abstract][Full Text] [Related]
3. Prophylaxis of Candida and Aspergillus infections with oral administration of itraconazole.
Van Cutsem J
Mycoses; 1994; 37(7-8):243-8. PubMed ID: 7739653
[TBL] [Abstract][Full Text] [Related]
4. Posaconazole: an extended-spectrum triazole antifungal agent.
Schiller DS; Fung HB
Clin Ther; 2007 Sep; 29(9):1862-86. PubMed ID: 18035188
[TBL] [Abstract][Full Text] [Related]
5. Itraconazole.
Piérard GE; Arrese JE; Piérard-Franchimont C
Expert Opin Pharmacother; 2000 Jan; 1(2):287-304. PubMed ID: 11249550
[TBL] [Abstract][Full Text] [Related]
6. Itraconazole: pharmacology, clinical experience and future development.
De Beule K
Int J Antimicrob Agents; 1996 Feb; 6(3):175-81. PubMed ID: 18611706
[TBL] [Abstract][Full Text] [Related]
7. Triazole antifungal agents in invasive fungal infections: a comparative review.
Lass-Flörl C
Drugs; 2011 Dec; 71(18):2405-19. PubMed ID: 22141384
[TBL] [Abstract][Full Text] [Related]
8. Fluconazole. An update of its pharmacodynamic and pharmacokinetic properties and therapeutic use in major superficial and systemic mycoses in immunocompromised patients.
Goa KL; Barradell LB
Drugs; 1995 Oct; 50(4):658-90. PubMed ID: 8536553
[TBL] [Abstract][Full Text] [Related]
9. Itraconazole: a new triazole antifungal agent.
Zuckerman JM; Tunkel AR
Infect Control Hosp Epidemiol; 1994 Jun; 15(6):397-410. PubMed ID: 8083506
[TBL] [Abstract][Full Text] [Related]
10. Itraconazole. A reappraisal of its pharmacological properties and therapeutic use in the management of superficial fungal infections.
Haria M; Bryson HM; Goa KL
Drugs; 1996 Apr; 51(4):585-620. PubMed ID: 8706596
[TBL] [Abstract][Full Text] [Related]
11. Novel triazole antifungal agents.
Hoffman HL; Ernst EJ; Klepser ME
Expert Opin Investig Drugs; 2000 Mar; 9(3):593-605. PubMed ID: 11060698
[TBL] [Abstract][Full Text] [Related]
12. Oral itraconazole therapy for superficial, subcutaneous, and systemic infections. A panoramic view.
De Rosso JQ; Gupta AK
Postgrad Med; 1999 Jul; Spec No():46-52. PubMed ID: 10492666
[TBL] [Abstract][Full Text] [Related]
13. Sertaconazole: a review of its use in the management of superficial mycoses in dermatology and gynaecology.
Croxtall JD; Plosker GL
Drugs; 2009; 69(3):339-59. PubMed ID: 19275277
[TBL] [Abstract][Full Text] [Related]
14. Optimisation of itraconazole therapy using target drug concentrations.
Poirier JM; Cheymol G
Clin Pharmacokinet; 1998 Dec; 35(6):461-73. PubMed ID: 9884817
[TBL] [Abstract][Full Text] [Related]
15. A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies. U.K. Multicentre Antifungal Prophylaxis Study Group.
Morgenstern GR; Prentice AG; Prentice HG; Ropner JE; Schey SA; Warnock DW
Br J Haematol; 1999 Jun; 105(4):901-11. PubMed ID: 10554799
[TBL] [Abstract][Full Text] [Related]
16. Itraconazole oral solution for primary prophylaxis of fungal infections in patients with hematological malignancy and profound neutropenia: a randomized, double-blind, double-placebo, multicenter trial comparing itraconazole and amphotericin B.
Harousseau JL; Dekker AW; Stamatoullas-Bastard A; Fassas A; Linkesch W; Gouveia J; De Bock R; Rovira M; Seifert WF; Joosen H; Peeters M; De Beule K
Antimicrob Agents Chemother; 2000 Jul; 44(7):1887-93. PubMed ID: 10858349
[TBL] [Abstract][Full Text] [Related]
17. Intraconazole--a new oral antifungal agent with a very broad spectrum of activity in superficial and systemic mycoses.
Odds FC
J Dermatol Sci; 1993 Apr; 5(2):65-72. PubMed ID: 8395201
[TBL] [Abstract][Full Text] [Related]
18. Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial.
Winston DJ; Maziarz RT; Chandrasekar PH; Lazarus HM; Goldman M; Blumer JL; Leitz GJ; Territo MC
Ann Intern Med; 2003 May; 138(9):705-13. PubMed ID: 12729424
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo antifungal activities of ER-30346, a novel oral triazole with a broad antifungal spectrum.
Hata K; Kimura J; Miki H; Toyosawa T; Nakamura T; Katsu K
Antimicrob Agents Chemother; 1996 Oct; 40(10):2237-42. PubMed ID: 8891121
[TBL] [Abstract][Full Text] [Related]
20. [New antifungal agents in the treatment of superficial dermatomycoses].
Degreef H
Ann Dermatol Venereol; 1993; 120(1):21-31. PubMed ID: 8393313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
